flickr facebook twitter digg stumbleupon feed

Fight against TB to Parliament

Our honourable chief guest, chair, ladies and gentlemen, the feedback on the state of tuberculosis (TB) in Uganda that we have just received has been quite insightful.

Starting with the technical team, they had a very rich discussion. They probed into the issues that we need to pay attention to. I think that they have identified, in various ways, the things that need to be paid attention to.

The administrators came out straight forward with issues around the financing of TB services. They were straight to the point. They were focused in what they had to recommend. They talked like administrators, “this is what we recommend.” They were fearless.

I want to thank the policy makers. They have pointed out areas that need consideration. They even went on to advise: “We think there is need for CPAR Uganda Ltd to take forward this matter of TB in Uganda to the Health Committee of Parliament to look into.” It means that work has to continue. I like it very much. They were straight to the point.

I think these ingredients make the work of collecting data, collating the data, and taking it forward a lot easier.

Although the time was limited, we could say more, at this point I can say the discussions were indeed very focused to what we would like to be looking forward to. Thank you very much.

I would like to thank everybody for the energy put in the workshops. Group work usually yields very good results and we have seen that today.

Thank you very much indeed.

Professor Dr. Christopher Garimoi Orach made these remarks in his capacity as the Board Chair of CPAR Uganda Ltd as he thanked 32 leaders – health experts, administrators and politicians – representing 13 district local governments, national government institutions, universities, private hospitals and civil society organisations, who participated in the high level policy workshops on TB in Uganda that were conducted by CPAR Uganda Ltd on Monday, 27th November 2017 in Gulu. The workshops are part of the two year research and advocacy project (January 2016 to December 2017) code named: “Tuberculosis: Working to Empower The Nations’ Diagnostic Efforts (TWENDE) that CPAR Uganda Ltd is implementing as part of a University of St. Andrews led Consortium. TWENDE is a team of academics and researchers, including the Managing Director of CPAR Uganda Ltd, that have joined together in a consortium to contribute towards breaking the cycle of the TB burden in East Africa. The lead TWENDE investigators include: research scientists, clinical researchers, pulmonologists, microbiologists, immunologists, paediatricians, physicians, public health specialists and a cultural anthropologist. The lead TWENDE investigators are from Uganda, Kenya, Tanzania and the United Kingdom (UK); and are affiliated to seven institutions that make up the TWENDE Consortium. TWENDE is funded by the European & Developing Countries Clinical Trials Partnership (EDCTP), under its EDCT2 programme, funded by the Horizon 2020 European Union funding for Research and Innovation.


Top updates

Weapon of Mass Destruction in Uganda 22 Feb 2018

 For full screen view, please click on this link http://cparuganda.com/videos/WEAPON_OF_MASS_D

More detail
Report on Training Qualitative Research Investigators 18 Feb 2018

Deducing from the trainees’ evaluation of the training, it is the conviction of CPAR Uganda Ltd that...

More detail
End TB Inform the Population 09 Feb 2018

  “It is where she was working as a maid for Indians that is where she got the problem. When you...

More detail

Twende Related